10 facts about the newest preventive migraine therapy
Neurologist explains why this drug class is winning the pain war
This content has been independently produced by ADG, made possible through sponsorship from Eli Lilly.
About a third of people with migraine would benefit from preventive treatment yet only a small proportion of those are receiving this therapy, and even then, discontinuation rates tend to be high, research shows.
